Previous Article | Next Article 
Infection and Immunity, January 2000, p. 38-45, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
DNA Vaccination with Genes Encoding
Toxoplasma gondii Antigens GRA1, GRA7, and ROP2 Induces
Partially Protective Immunity against Lethal Challenge in
Mice
M.
Vercammen,1,*
T.
Scorza,1
K.
Huygen,2
J.
De
Braekeleer,3
R.
Diet,1
D.
Jacobs,4
E.
Saman,4 and
H.
Verschueren3
Department of
Toxoplasmosis,1 Department of
Mycobacterial Immunology,2 and
Department of Cell Biology,3 Pasteur
Institute of Brussels, Brussels, and Innogenetics,
Industriepark Zwijnaarde, Ghent,4 Belgium
Received 4 May 1999/Returned for modification 14 June 1999/Accepted 5 October 1999
C57BL/6, C3H, and BALB/c mice were vaccinated with plasmids
encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2,
previously described as strong inducers of immunity. Seroconversion for
the relevant antigen was obtained in the majority of the animals. T. gondii lysate stimulated specific T-cell proliferation
and secretion of gamma interferon (IFN-
) in spleen cell cultures from vaccinated BALB/c and C3H mice but not in those from control mice.
Although not proliferating, stimulated splenocytes from DNA-vaccinated
C57BL/6 mice also produced IFN-
. No interleukin-4 was detected in
the supernatants of lysate-stimulated splenocytes from DNA-vaccinated
mice in any of the mouse strains evaluated. As in infected animals, a
high ratio of specific immunoglobulin G2a (IgG2a) to IgG1 antibodies
was found in DNA-vaccinated C3H mice, suggesting that a Th1-type
response had been induced. For BALB/c mice, the isotype ratio of the
antibody response to DNA vaccination was less polarized. The protective
potential of DNA vaccination was demonstrated in C3H mice. C3H mice
vaccinated with plasmid encoding GRA1, GRA7, or ROP2 were partially
protected against a lethal oral challenge with cysts of two different
T. gondii strains: survival rates increased from 10% in
controls to at least 70% after vaccination in one case and from 50%
to at least 90% in the other. In vaccinated C3H mice challenged with a
nonlethal T. gondii dose, the number of brain cysts was
significantly lower than in controls. DNA vaccination did not protect
BALB/c or C57BL/6 mice. Our results demonstrate for the first time in an animal model a partially protective effect of DNA vaccination against T. gondii.
*
Corresponding author. Mailing address: Department of
Toxoplasmosis, Pasteur Institute, Engelandstraat 642, B-1180
Brussels, Belgium. Phone: 32.2.373.32.03. Fax:
32.2.373.32.81. E-mail:
mvercamm{at}ben.vub.ac.be.
Infection and Immunity, January 2000, p. 38-45, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Okamba, F. R., Moreau, E., Cheikh Saad Bouh, K., Gagnon, C. A., Massie, B., Arella, M.
(2007). Immune Responses Induced by Replication-Defective Adenovirus Expressing the C-Terminal Portion of the Mycoplasma hyopneumoniae P97 Adhesin. CVI
14: 767-774
[Abstract]
[Full Text]
-
Chen, Y.-S., Hsiao, Y.-S., Lin, H.-H., Liu, Y., Chen, Y.-L.
(2006). CpG-Modified Plasmid DNA Encoding Flagellin Improves Immunogenicity and Provides Protection against Burkholderia pseudomallei Infection in BALB/c Mice. Infect. Immun.
74: 1699-1705
[Abstract]
[Full Text]
-
Martin, V., Supanitsky, A., Echeverria, P. C., Litwin, S., Tanos, T., De Roodt, A. R., Guarnera, E. A., Angel, S. O.
(2004). Recombinant GRA4 or ROP2 Protein Combined with Alum or the gra4 Gene Provides Partial Protection in Chronic Murine Models of Toxoplasmosis. CVI
11: 704-710
[Abstract]
[Full Text]
-
Vonlaufen, N., Guetg, N., Naguleswaran, A., Muller, N., Bjorkman, C., Schares, G., von Blumroeder, D., Ellis, J., Hemphill, A.
(2004). In Vitro Induction of Neospora caninum Bradyzoites in Vero Cells Reveals Differential Antigen Expression, Localization, and Host-Cell Recognition of Tachyzoites and Bradyzoites. Infect. Immun.
72: 576-583
[Abstract]
[Full Text]
-
Ismael, A. B., Sekkai, D., Collin, C., Bout, D., Mevelec, M.-N.
(2003). The MIC3 Gene of Toxoplasma gondii Is a Novel Potent Vaccine Candidate against Toxoplasmosis. Infect. Immun.
71: 6222-6228
[Abstract]
[Full Text]
-
Fachado, A., Rodriguez, A., Molina, J., Silverio, J. C., Marino, A. P. M. P., Pinto, L. M. O., Angel, S. O., Infante, J. F., Traub-Cseko, Y., Amendoeira, R. R., Lannes-Vieira, J.
(2003). Long-Term Protective Immune Response Elicited by Vaccination with an Expression Genomic Library of Toxoplasma gondii. Infect. Immun.
71: 5407-5411
[Abstract]
[Full Text]
-
Chen, Y.-L., Wang, S.-N., Yang, W.-J., Chen, Y.-J., Lin, H.-H., Shiuan, D.
(2003). Expression and Immunogenicity of Mycoplasma hyopneumoniae Heat Shock Protein Antigen P42 by DNA Vaccination. Infect. Immun.
71: 1155-1160
[Abstract]
[Full Text]
-
Scorza, T., D'Souza, S., Laloup, M., Dewit, J., De Braekeleer, J., Verschueren, H., Vercammen, M., Huygen, K., Jongert, E.
(2003). A GRA1 DNA Vaccine Primes Cytolytic CD8+ T Cells To Control Acute Toxoplasma gondii Infection. Infect. Immun.
71: 309-316
[Abstract]
[Full Text]
-
Fatoohi, A. F., Cozon, G. J. N., Greenland, T., Ferrandiz, J., Bienvenu, J., Picot, S., Peyron, F.
(2002). Cellular Immune Responses to Recombinant Antigens in Pregnant Women Chronically Infected with Toxoplasma gondii. CVI
9: 704-707
[Abstract]
[Full Text]
-
Tanghe, A., Content, J., Van Vooren, J.-P., Portaels, F., Huygen, K.
(2001). Protective Efficacy of a DNA Vaccine Encoding Antigen 85A from Mycobacterium bovis BCG against Buruli Ulcer. Infect. Immun.
69: 5403-5411
[Abstract]
[Full Text]
-
Tanghe, A., Denis, O., Lambrecht, B., Motte, V., van den Berg, T., Huygen, K.
(2000). Tuberculosis DNA Vaccine Encoding Ag85A Is Immunogenic and Protective When Administered by Intramuscular Needle Injection but Not by Epidermal Gene Gun Bombardment. Infect. Immun.
68: 3854-3860
[Abstract]
[Full Text]